Given low clinical trial enrollment among adult oncology patients, understanding current research responsibilities of APs could lead to identification of opportunities to leverage this workforce to enhance accrual and conduct of clinical trials.
![[Abstract #95] Role of Oncology Advanced Practitioners to Enhance Clinical Research](https://cdn.sanity.io/images/0vv8moc6/accc-cancer/640e3d97d4e346f3bcdcf70c242420ee58c95be0-394x230.png?fit=crop&auto=format)
Presented at the 2020 ASCO Quality Care Symposium, October 9 to October 10, 2020.
Authors
Christa M. Braun-Inglis, NP1, Leigh M. Boehmer, PharmD2, Laura J. Zitella, NP3, Brianna W. Hoffner, NP4, Yurii B. Shvetsov, PhD1, Jessica M. Rhee, MD1, Randall A. Oyer, MD5, Al B. Benson, III, MD6
1University of Hawaii Cancer Center, Honolulu, HI; 2Association of Cancer Care Centers, Rockville, MD; 3University of California, San Francisco, CA; 4Harborside, Huntington, NY; 5Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, PA; 6Northwestern Medicine, Chicago, IL
Background
Oncology Advanced Practitioners (APs), including nurse practitioners, clinical nurse specialists, physician assistants and pharmacists, are highly trained, skilled health care providers that contribute significantly to quality cancer care.
Given low clinical trial enrollment among adult oncology patients, understanding current research responsibilities of APs could lead to identification of opportunities to leverage this workforce to enhance accrual and conduct of clinical trials.
Access more clinical research and trials content in the 2020-21 ACCC President’s Theme, Community Oncology Can Close the Gap in Cancer Research.
